Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

Clinical trial update for S.P.PRO LIVER POWDER in Phase 4 assessing improvements in liver and metabolic indices in non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S.P.PRO LIVER POWDER

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Liver Diseases | Phase 4 | Status: UNKNOWN